---
title: "MOORE YAN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/8aa76320-e824-5af8-be5d-b05128738ee6
json: https://whiteintel.dev/api/public/dossier/8aa76320-e824-5af8-be5d-b05128738ee6
identifier: sec:0001901999
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MOORE YAN

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001901999`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/8aa76320-e824-5af8-be5d-b05128738ee6  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/8aa76320-e824-5af8-be5d-b05128738ee6  

## Ownership & control

### Holdings / subsidiaries

- **Omega Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/ec10a2c4-d10a-57b2-b8ea-5241ccfc0139

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MOORE YAN**. Human view: https://whiteintel.dev/entity/8aa76320-e824-5af8-be5d-b05128738ee6 · Structured JSON: https://whiteintel.dev/api/public/dossier/8aa76320-e824-5af8-be5d-b05128738ee6._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._